 Karen Gieseker
Concepts (120)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Neisseria gonorrhoeae | 2 | 2021 | 20 | 1.030 |
Why?
| | Gonorrhea | 2 | 2021 | 54 | 0.970 |
Why?
| | Hazardous Substances | 1 | 2011 | 12 | 0.400 |
Why?
| | Drug Therapy | 1 | 2011 | 76 | 0.380 |
Why?
| | Occupational Exposure | 1 | 2011 | 277 | 0.310 |
Why?
| | Multiple Sclerosis | 2 | 2011 | 384 | 0.290 |
Why?
| | Air Pollutants | 1 | 2008 | 316 | 0.240 |
Why?
| | Bacterial Typing Techniques | 1 | 2003 | 43 | 0.230 |
Why?
| | Streptococcus pyogenes | 1 | 2003 | 35 | 0.230 |
Why?
| | Pharyngitis | 1 | 2003 | 25 | 0.230 |
Why?
| | Antigens, Bacterial | 1 | 2003 | 116 | 0.220 |
Why?
| | Ceftriaxone | 1 | 2021 | 17 | 0.210 |
Why?
| | Azithromycin | 1 | 2021 | 81 | 0.200 |
Why?
| | Streptococcal Infections | 1 | 2003 | 141 | 0.200 |
Why?
| | Demography | 1 | 2021 | 274 | 0.190 |
Why?
| | Drug Resistance, Bacterial | 1 | 2021 | 155 | 0.190 |
Why?
| | Microbial Sensitivity Tests | 1 | 2021 | 302 | 0.190 |
Why?
| | Epidemiologic Research Design | 1 | 1997 | 30 | 0.160 |
Why?
| | beta-Endorphin | 2 | 1994 | 7 | 0.150 |
Why?
| | Pituitary Gland | 2 | 1994 | 163 | 0.140 |
Why?
| | Dietary Fats | 1 | 1997 | 322 | 0.130 |
Why?
| | Fatty Acids | 1 | 1997 | 407 | 0.130 |
Why?
| | Anti-Bacterial Agents | 3 | 2021 | 1510 | 0.120 |
Why?
| | Pregnancy, Ectopic | 1 | 2011 | 53 | 0.100 |
Why?
| | Operating Rooms | 1 | 2011 | 90 | 0.090 |
Why?
| | Maternal Health Services | 1 | 2010 | 83 | 0.080 |
Why?
| | Georgia | 1 | 2008 | 61 | 0.080 |
Why?
| | Female | 9 | 2021 | 61564 | 0.080 |
Why?
| | United States | 2 | 2021 | 12554 | 0.070 |
Why?
| | Aflatoxins | 1 | 2005 | 3 | 0.070 |
Why?
| | Food Contamination | 1 | 2005 | 45 | 0.070 |
Why?
| | Zea mays | 1 | 2005 | 47 | 0.070 |
Why?
| | Male | 8 | 2021 | 57800 | 0.070 |
Why?
| | Humans | 11 | 2021 | 118969 | 0.060 |
Why?
| | Policy Making | 1 | 2005 | 86 | 0.060 |
Why?
| | Foodborne Diseases | 1 | 2005 | 49 | 0.060 |
Why?
| | Environmental Exposure | 1 | 2008 | 405 | 0.060 |
Why?
| | Neoplasms | 1 | 1997 | 2179 | 0.060 |
Why?
| | Health Promotion | 1 | 2010 | 691 | 0.060 |
Why?
| | Reagent Kits, Diagnostic | 1 | 2003 | 42 | 0.060 |
Why?
| | Disease Outbreaks | 1 | 2005 | 322 | 0.060 |
Why?
| | Immunoassay | 1 | 2003 | 101 | 0.060 |
Why?
| | Arthritis, Rheumatoid | 1 | 2011 | 989 | 0.050 |
Why?
| | Meningitis, Viral | 1 | 2002 | 22 | 0.050 |
Why?
| | Hospital Charges | 1 | 2002 | 42 | 0.050 |
Why?
| | Specimen Handling | 1 | 2003 | 165 | 0.050 |
Why?
| | Pregnancy | 2 | 2011 | 5691 | 0.050 |
Why?
| | Appendicitis | 1 | 2003 | 125 | 0.050 |
Why?
| | Enterovirus | 1 | 2002 | 72 | 0.050 |
Why?
| | Evidence-Based Medicine | 1 | 2005 | 693 | 0.050 |
Why?
| | Public Health | 1 | 2005 | 450 | 0.050 |
Why?
| | Sexual Partners | 1 | 2021 | 159 | 0.050 |
Why?
| | DNA, Viral | 1 | 2002 | 356 | 0.050 |
Why?
| | Enterovirus Infections | 1 | 2002 | 164 | 0.040 |
Why?
| | Societies, Medical | 1 | 2003 | 703 | 0.040 |
Why?
| | Hospitals, Pediatric | 1 | 2003 | 505 | 0.040 |
Why?
| | Surveys and Questionnaires | 2 | 2008 | 4708 | 0.040 |
Why?
| | Sensitivity and Specificity | 1 | 2003 | 1795 | 0.040 |
Why?
| | Nutritional Physiological Phenomena | 1 | 1997 | 54 | 0.040 |
Why?
| | Cross-Sectional Studies | 1 | 2008 | 4552 | 0.040 |
Why?
| | Sexual Behavior | 1 | 2021 | 437 | 0.040 |
Why?
| | Bufo marinus | 2 | 1994 | 4 | 0.040 |
Why?
| | Genomics | 1 | 2021 | 706 | 0.040 |
Why?
| | Chromatography, High Pressure Liquid | 2 | 1994 | 490 | 0.030 |
Why?
| | Practice Patterns, Physicians' | 1 | 2003 | 1199 | 0.030 |
Why?
| | Endopeptidases | 1 | 1994 | 73 | 0.030 |
Why?
| | Radioimmunoassay | 1 | 1993 | 165 | 0.030 |
Why?
| | Chromatography, Gel | 1 | 1993 | 133 | 0.030 |
Why?
| | Child | 4 | 2005 | 19129 | 0.030 |
Why?
| | Prospective Studies | 1 | 2003 | 6471 | 0.030 |
Why?
| | Protein Processing, Post-Translational | 1 | 1994 | 408 | 0.020 |
Why?
| | Tanzania | 1 | 2010 | 45 | 0.020 |
Why?
| | Community Health Workers | 1 | 2010 | 49 | 0.020 |
Why?
| | Length of Stay | 2 | 2003 | 1031 | 0.020 |
Why?
| | Health Education | 1 | 2010 | 318 | 0.020 |
Why?
| | Population Surveillance | 1 | 2010 | 413 | 0.020 |
Why?
| | DNA Adducts | 1 | 2005 | 14 | 0.020 |
Why?
| | Infant | 3 | 2005 | 8293 | 0.020 |
Why?
| | Hepatitis B Surface Antigens | 1 | 2005 | 19 | 0.020 |
Why?
| | Food Handling | 1 | 2005 | 48 | 0.020 |
Why?
| | Kenya | 1 | 2005 | 100 | 0.020 |
Why?
| | Program Evaluation | 1 | 2010 | 845 | 0.020 |
Why?
| | Child, Preschool | 3 | 2005 | 9491 | 0.020 |
Why?
| | Referral and Consultation | 1 | 2010 | 648 | 0.020 |
Why?
| | Health Status Indicators | 1 | 2005 | 154 | 0.020 |
Why?
| | Risk Factors | 1 | 1997 | 8999 | 0.010 |
Why?
| | Rupture, Spontaneous | 1 | 2003 | 18 | 0.010 |
Why?
| | Regression Analysis | 1 | 2005 | 983 | 0.010 |
Why?
| | Appendectomy | 1 | 2003 | 73 | 0.010 |
Why?
| | Emergency Medical Services | 1 | 2010 | 589 | 0.010 |
Why?
| | Health Policy | 1 | 2005 | 333 | 0.010 |
Why?
| | Survival Analysis | 1 | 2005 | 1267 | 0.010 |
Why?
| | Hospital Costs | 1 | 2003 | 110 | 0.010 |
Why?
| | Drug Costs | 1 | 2003 | 94 | 0.010 |
Why?
| | Cerebrospinal Fluid | 1 | 2002 | 93 | 0.010 |
Why?
| | Health Resources | 1 | 2003 | 132 | 0.010 |
Why?
| | Patient Admission | 1 | 2003 | 176 | 0.010 |
Why?
| | Adolescent | 3 | 2005 | 18479 | 0.010 |
Why?
| | Diagnostic Imaging | 1 | 2003 | 294 | 0.010 |
Why?
| | Acute Disease | 1 | 2003 | 940 | 0.010 |
Why?
| | Combined Modality Therapy | 1 | 2003 | 1166 | 0.010 |
Why?
| | Polymerase Chain Reaction | 1 | 2002 | 1012 | 0.010 |
Why?
| | Laparoscopy | 1 | 2003 | 417 | 0.010 |
Why?
| | Treatment Outcome | 2 | 2003 | 9342 | 0.010 |
Why?
| | Case-Control Studies | 1 | 2005 | 3171 | 0.010 |
Why?
| | Diagnosis, Differential | 1 | 2002 | 1384 | 0.010 |
Why?
| | Risk Assessment | 1 | 2005 | 3057 | 0.010 |
Why?
| | Animals | 2 | 1994 | 33381 | 0.010 |
Why?
| | Chromatography, Ion Exchange | 1 | 1994 | 51 | 0.010 |
Why?
| | Molecular Weight | 1 | 1994 | 343 | 0.010 |
Why?
| | Sequence Homology, Amino Acid | 1 | 1994 | 372 | 0.010 |
Why?
| | Substrate Specificity | 1 | 1994 | 371 | 0.010 |
Why?
| | Infant, Newborn | 1 | 2003 | 5255 | 0.010 |
Why?
| | Time Factors | 1 | 2002 | 6412 | 0.010 |
Why?
| | Amino Acid Sequence | 1 | 1994 | 2071 | 0.010 |
Why?
| | Molecular Sequence Data | 1 | 1994 | 2871 | 0.010 |
Why?
| | Aged | 1 | 2005 | 19656 | 0.000 |
Why?
| | Middle Aged | 1 | 2005 | 27617 | 0.000 |
Why?
| | Retrospective Studies | 1 | 2002 | 12975 | 0.000 |
Why?
| | Adult | 1 | 2005 | 31510 | 0.000 |
Why?
|
|
Gieseker's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|